Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint

被引：46

作者：

Fu, Kai-Yuan ^{[1
,2
,3
,4
]}

Chen, Hui-Min

Sun, Zhi-Peng ^{[1
,2
,3
,4
]}

Zhang, Zhen-Kang

Ma, Xu-Chen ^{[1
,2
,3
,4
]}

机构：

[1] Peking Univ, Sch Stomatol, Ctr TMD & Orofacial Pain, Beijing 100081, Peoples R China

[2] Peking Univ, Hosp Stomatol, Ctr TMD & Orofacial Pain, Beijing 100081, Peoples R China

[3] Peking Univ, Dept Oral & Maxillofacial Radiol, Sch Stomatol, Beijing 100081, Peoples R China

[4] Peking Univ, Dept Oral & Maxillofacial Radiol, Hosp Stomatol, Beijing 100081, Peoples R China

来源：

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY | 2010年 / 48卷 / 04期

关键词：

Temporomandibular joint; Dislocation; Botulinum toxin type A; Lateral pterygoid muscle; RECURRENT DISLOCATION;

D O I：

10.1016/j.bjoms.2009.07.014

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

Injection of botulinum toxin type A (BTX-A) into the lateral pterygoid muscles is a recently reported treatment for habitual dislocation of the temporomandibular joint (TMJ). We report live cases of dislocation in elderly patients with neurological or other severe systemic disease, and their successful treatment with one injection of BTX-A into the lateral pterygoid muscles. This is a relatively conservative option. Injection into the muscle is straightforward and can be done in outpatients with few complications. We recommend it as the first choice for patients with habitual dislocation and systemic or neurological diseases, particularly in the elderly. (C) 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

引用

页码：281 / 284

页数：4

共 14 条

[1] Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A [J].